Annual Review of Cancer Biology

Papers
(The TQCC of Annual Review of Cancer Biology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
55
44
Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor–Based Cellular Therapy25
Immune Cell Metabolism and Immuno-Oncology23
Tracing and Targeting the Origins of Childhood Cancer22
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells in Vivo19
Development of PROTAC Degrader Drugs for Cancer18
Clonal Hematopoiesis: Confluence of Malignant and Nonmalignant Diseases18
Not All Carcinogens Are Directly Mutagenic: A Holistic View of the Environmental Exposure–Cancer Connection18
The Metabolic Relationship Between Viral Infection and Cancer15
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches13
RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations13
Therapeutic Targeting of the Menin–KMT2A Interaction13
Next-Generation Therapies for Multiple Myeloma12
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer12
Applications of Digital Pathology in Cancer: A Comprehensive Review12
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond11
New Tools for Lineage Tracing in Cancer In Vivo10
Studying Progression from Chronic Injury to Esophageal Adenocarcinoma10
Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint Blockade10
0.086657047271729